Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk.
Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk.
复制标题
DOI:
10.1001/jama.1996.03540180050032
复制
发表时间:
1996-11
期刊:
影响因子:
--
通讯作者:
C. Ambrosone;J. Freudenheim;S. Graham;J. Marshall;J. Vena;J. Brasure;A. Michalek;R. Laughlin;Takuma Nemoto;K. Gillenwater;A. M. Harrington;P. Shields
中科院分区:
文献类型:
--
作者:
C. Ambrosone;J. Freudenheim;S. Graham;J. Marshall;J. Vena;J. Brasure;A. Michalek;R. Laughlin;Takuma Nemoto;K. Gillenwater;A. M. Harrington;P. Shields
OBJECTIVE To determine if N-acetyltransferase 2 (NAT2) polymorphisms result in decreased capacity to detoxify carcinogenic aromatic amines in cigarette smoke, thus making some women who smoke more susceptible to breast cancer. DESIGN Case-control study with genetic analyses. DNA analyses were performed for 3 polymorphisms accounting for 90% to 95% of the slow acetylation phenotype among whites. SETTING AND PARTICIPANTS White women with incident primary breast cancer (n=304) and community controls (n=327). RESULTS Neither smoking nor NAT2 status was independently associated with breast cancer risk. There were no clear patterns of increased risk associated with smoking by NAT2 status among premenopausal women. In postmenopausal women, NAT2 strongly modified the association of smoking with risk. For slow acetylators, current smoking and smoking in the distant past increased breast cancer risk in a dose-dependent manner (odds ratios [95% confidence intervals] for the highest quartile of cigarettes smoked 2 and 20 years previously, 4.4 [1.3-14.8] and 3.9 [1.4-10.8], respectively). Among rapid acetylators, smoking was not associated with increased breast cancer risk. CONCLUSIONS Our results suggest that smoking may be an important risk factor for breast cancer among postmenopausal women who are slow acetylators, demonstrate heterogeneity in response to carcinogenic exposures, and may explain previous inconsistent findings for cigarette smoking as a breast cancer risk factor.